Arcadia Biosciences Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
01 Feb 24 | BuyUS$1,442 | Thomas Schaefer | Individual | 700 | US$2.06 | |
04 Aug 23 | BuyUS$2,382 | Thomas Schaefer | Individual | 649 | US$3.67 | |
30 May 23 | BuyUS$21,550 | Stanley Jacot | Individual | 5,000 | US$4.31 |
Insider Trading Volume
Insider Buying: RKDA insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Individual Insiders | 7,261 | 0.533% |
Private Companies | 31,024 | 2.28% |
Institutions | 103,681 | 7.61% |
Hedge Funds | 180,305 | 13.2% |
General Public | 1,040,569 | 76.4% |
Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 58.9%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
97,305 | US$190.7k | 198% | 1.06% | |||
83,000 | US$162.7k | 0% | 0.09% | |||
58,315 | US$114.3k | 0% | no data | |||
28,144 | US$55.2k | 0% | no data | |||
14,038 | US$27.5k | 82.7% | no data | |||
12,146 | US$23.8k | 0% | no data | |||
11,370 | US$22.3k | 0% | no data | |||
7,019 | US$13.8k | 2.93% | no data | |||
5,000 | US$9.8k | 0% | no data | |||
2,880 | US$5.6k | 24.6% | no data | |||
1,419 | US$2.8k | 97.4% | no data | |||
508 | US$995.8 | 0% | no data | |||
500 | US$980.1 | 0% | no data | |||
214 | US$419.4 | 0% | no data | |||
207 | US$405.8 | 0% | no data | |||
128 | US$250.8 | 0% | no data | |||
38 | US$74.5 | 0% | no data | |||
18 | US$35.3 | 0% | no data | |||
9 | US$17.6 | 12.5% | no data | |||
5 | US$9.9 | 0% | no data | |||
4 | US$7.7 | 0% | no data | |||
2 | US$4.0 | 0% | no data | |||
1 | US$1.9 | 0% | no data | |||
1 | US$1.9 | 0% | no data |